celecoxib and bromodeoxyuridine

celecoxib has been researched along with bromodeoxyuridine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosland, MC; Condon, MS; Narayanan, BA; Narayanan, NK; Reddy, BS1
Barnard, GF; Do, K1
Singh, S1

Other Studies

3 other study(ies) available for celecoxib and bromodeoxyuridine

ArticleYear
Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s).
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Aug-15, Volume: 9, Issue:9

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Bromodeoxyuridine; Carcinogens; Celecoxib; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Coloring Agents; Cyclin D; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cyclooxygenase 2; DNA; Dose-Response Relationship, Drug; Down-Regulation; Flow Cytometry; Immunohistochemistry; Isoenzymes; Male; Methylnitrosourea; Microscopy, Fluorescence; Models, Biological; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Pyrazoles; Rats; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Time Factors; Tumor Suppressor Proteins

2003
Effect of concomitant polyethylene glycol and celecoxib on colonic aberrant crypt foci and tumors in F344 rats.
    Digestive diseases and sciences, 2005, Volume: 50, Issue:7

    Topics: Animals; Azoxymethane; Bromodeoxyuridine; Celecoxib; Colon; Colonic Neoplasms; Cyclooxygenase Inhibitors; Cytoprotection; Drug Synergism; Female; Immunohistochemistry; Male; Polyethylene Glycols; Pyrazoles; Rats; Rats, Inbred F344; Staining and Labeling; Sulfonamides

2005
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells.
    International journal of nanomedicine, 2018, Volume: 13, Issue:T-NANO 201

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Celecoxib; Cell Line, Tumor; Cell Survival; Disease Progression; Doxorubicin; Humans; Liposomes; Particle Size; Skin Neoplasms; Static Electricity

2018